Literature DB >> 2460835

Selective vibration sensing: a new concept for activity-sensing rate-responsive pacing.

C P Lau1, J R Stott, W D Toff, M B Zetlein, D E Ward, A J Camm.   

Abstract

A clinically available model of an activity-sensing, rate-responsive pacemaker (Activitrax, Medtronic) utilizes body vibration during exercise as an indicator of the need for a rate increase. Although having the advantage of rapid onset of rate response, this system lacks specificity and the rate response does not closely correlate with the level of exertion. In addition, this pacemaker is susceptible to the effects of extraneous vibration. In this study involving 20 normal subjects fitted with an external Activitrax pacemaker, the rate responses to a variety of exercises were studied and were compared with the corresponding sinus rates. The vibration generated at the level of the pacemaker was also measured by accelerometers in three axes. Only a fair correlation (r = 0.51) was achieved between the pacemaker rate and the sinus rate. The total root mean square value of acceleration in either the anteroposterior or the vertical axes was found to have a better correlation (r = 0.8). As the main accelerations during physical activities were in the lower frequency range (0.1-4 Hz), a low-pass filter was used to reduce the influence of extraneous vibration. Selective sensing of the acceleration level may be usefully implemented in an algorithm for activity pacing.

Mesh:

Year:  1988        PMID: 2460835     DOI: 10.1111/j.1540-8159.1988.tb03992.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Indications and choices in pacemaker therapy.

Authors:  J Benrey
Journal:  Tex Heart Inst J       Date:  1991

2.  Activity-based rate-adaptive pacemakers under hyperbaric conditions.

Authors:  Alexandre Trigano; Vincent Lafay; Olivier Blandeau; Samuel Levy; Bernard Gardette; Christophe Micoli
Journal:  J Interv Card Electrophysiol       Date:  2006-08-10       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.